ACP1 and melanoma: These results could have important implications in the field of anticancer therapies because they demonstrate the importance of this enzyme as a target to control melanoma cell growth and highlight the possibility to use LMW‐PTP inhibitors to develop new adjuvant‐based anticancer therapies beneficial for the treatment of metastatic melanoma and other kind of drug‐resistant cancers.